Drug Shortage Report for RISEDRONATE

Last updated on 2017-05-16 History
Report ID 5675
Drug Identification Number 02411407
Brand name RISEDRONATE-35
Common or Proper name RISEDRONATE-35
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) RISEDRONATE SODIUM
Strength(s) 35MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-04-04
Estimated end date
Actual end date 2017-05-15
Shortage status Resolved
Updated date 2017-05-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2017-05-16 English Compare
v13 2017-05-03 French Compare
v12 2017-05-03 English Compare
v11 2017-04-27 French Compare
v10 2017-04-27 English Compare
v9 2017-04-27 English Compare
v8 2017-04-25 French Compare
v7 2017-04-25 English Compare
v6 2017-04-25 English Compare
v5 2017-04-05 French Compare
v4 2017-04-05 English Compare
v3 2017-04-05 French Compare
v2 2017-04-05 English Compare
v1 2017-04-05 English Compare

Showing 1 to 14 of 14